Search Results - "NAGASAKA, M"

Non–Small Cell Lung Cancer: Does Histology Matter? by Nagasaka, M, Sukari, A

Get full text

Tiragolumab (Anti-TIGIT) in SCLC: Skyscraper-02, a Towering Inferno by Brazel, Danielle, Ou, Sai-Hong Ignatius, Nagasaka, Misako

“…Small cell lung cancer (SCLC) is characterized by rapid progression and poor prognosis. Although the phase II CITYSCAPE-02 trial found objective response rate…”
Get full text

A Long Overdue Targeted Treatment for KRAS Mutations in NSCLC: Spotlight on Adagrasib by Brazel, Danielle, Arter, Zhaohui, Nagasaka, Misako

“…[KRAS.sup.G12C] is one of the most common oncogenes in non-small cell lung cancer (NSCLC) and is associated with a poor prognosis. Historically, KRAS mutations…”
Get full text

The allure of ‘ALUR’ by Nagasaka, M., Zhu, V.W., Ou, S.-H.I.

Get full text

Proteoglycan Expression Is Influenced by Mechanical Load in TMJ Discs by Nakao, Y., Konno-Nagasaka, M., Toriya, N., Arakawa, T., Kashio, H., Takuma, T., Mizoguchi, I.

“…The expression and assembly of the extracellular matrix are profoundly associated with adaptive and pathological responses of the temporomandibular joint…”
Get full text

Proton transfer in a two-dimensional hydrogen-bonding network: water and hydroxyl on a pt(111) surface by Nagasaka, M, Kondoh, H, Amemiya, K, Ohta, T, Iwasawa, Y

“…The time scale of proton transfer between H(2)O and OH adsorbed on a Pt(111) surface was determined by a combination of laser-induced thermal desorption (LITD)…”
Get full text

559P Comprehensive survey of AACR GENIE database revealed a wide range of TMB distribution among all three classes (I, II, III) of BRAF mutated NSCLC by Arter, Z.L., Nagasaka, M., Ou, S-H.I.

Get full text

485P LDCT lung cancer screening of never-smokers meta-analysis subgroup analysis: Adenocarcinoma is the highly predictive histology identified in never-smokers by Triphuridet, N., Nagasaka, M., Shum, E., Ou, S-H.I.

Get full text

PD-23 Comprehensive survey of AACR GENIE cBioPortal database of receptor tyrosine kinase fusion in colorectal carcinoma identified high co-occurring genomic alterations in NTRK1 & RET fusion-positive CRC by Lee, A., Arter, Z., Cho, M., Nagasaka, M., Ou, S.

Get full text

Element-selective vertical height determination for an organic monolayer by a scanned-energy photoelectron-yield soft x-ray standing wave technique by Kondoh, H., Yokota, R., Amemiya, K., Shimada, T., Nakai, I., Nagasaka, M., Ohta, T., Nakamura, T., Takenaka, H.

“…A photoelectron-yield soft x-ray standing wave (SW) technique with the scanned-energy mode has been applied to the vertical height determination of the atoms…”
Get full text

A Prospective Survey Study of Radiation Therapy Patient Interest in Psychedelic Research by Park, J., Ku, E.C.Y., Harada, G.K., Hoyt, M.A., Nagasaka, M., Harris, J.P.

“…About 25-30% of patients diagnosed with cancer have a comorbid mental health illness, most commonly mood disorders (depression/anxiety). Early work…”
Get full text

Severity of Financial Toxicity for Patients Receiving Palliative Radiation Therapy by Harris, J.P., Hsu, S., Ku, E.C.Y., Nagasaka, M., Kuo, J.V., Healy, E.

“…Patients receiving palliative radiotherapy (RT) are often at their most vulnerable state, but the impact of financial toxicity on their health and quality of…”
Get full text

70 (PB058): Phase 1/2 clinical trial of JIN-A02, a 4th generation EGFR-tyrosine kinase inhibitor (TKI), in patients with 3rd generation EGFR-TKI resistance in EGFR mutated advanced/metastatic non-small cell lung cancer (NSCLC) by Lim, S.M., Cho, B.C., Han, J.Y., Kim, S.W., Lee, K.H., Nagasaka, M., Jo, A., Seah, E., Kim, C., Reungwetwattana, T.

Get full text

Study on 12/21-GHz Dual-circularly Polarized Receiving Antenna for Satellite Broadcasting by Nagasaka, M., Nakazawa, S., Tanaka, S.

“…In December 2018, satellite broadcasting of ultra-high-definition television (UHDTV) will begin in Japan. For broadcasting UHDTV, BSAT-4a satellite was…”
Get full text

A Single-Arm Pilot Study of Combined SBRT and Electric Ablation for Lung Tumors by Harris, J.P., Abi-Jaoudeh, N., Boyd, C., Shi, M., Reilly, M.P., Simon, A.B., Seyedin, S.N., Healy, E., McLaren, C., Nagasaka, M., Banker, R., Chen, A.M.

“…Although stereotactic body radiation therapy (SBRT) is widely utilized for lung metastases, achieving local control while minimizing adverse events is…”
Get full text

Spotlight on Cemiplimab-rwlc in the Treatment of Non-Small Cell Lung Cancer (NSCLC): Focus on Patient Selection and Considerations by Ahn, Jeffrey, Nagasaka, Misako

“…In metastatic non-small cell lung cancer (NSCLC), tumors that do not harbor driver mutations in EGFR or gene fusions in ALK and ROS, PD-1 and PD-L1 inhibitors…”
Get full text

MARIPOSA: Can Amivantamab and Lazertinib Replace Osimertinib in the Front-Line Setting? by Brazel, Danielle, Nagasaka, Misako

“…Osimertinib is the current first-line treatment for EGFR-mutated NSCLC, however, patients frequently relapse due to acquired resistance mutations. Amivantamab…”
Get full text

597TiP A phase I/II study to evaluate the safety and anti-tumor activity of JIN-A02 in patients with EGFR TKI-refractory, EGFR-mutant advanced NSCLC by Lim, S.M., Cho, B.C., Han, J-Y., Kim, S-W., Lee, K.H., Nagasaka, M., Baisamut, T.R., Jo, A., Seah, E., Kim, C., Ou, S-H.I.

Get full text

Spotlight on Amivantamab (JNJ-61186372) for EGFR Exon 20 Insertions Positive Non-Small Cell Lung Cancer by Brazel, Danielle, Nagasaka, Misako

“…Non-small cell lung cancer (NSCLC) patients demonstrating sensitizing oncogenic driver mutations have derived clinical benefit from targeted therapy. EGFR…”
Get full text

The Butterfly Flies - Practice Changing Results of PAPILLON, First Line Chemotherapy and Amivantamab for the Treatment of NSCLC Patients with EGFR Exon 20 Insertions by Kaakour, Dalia, Nagasaka, Misako

“…Epidermal growth factor receptor (EGFR) exon 20 insertions are a rare subtype of EGFR mutations that do not respond to EGFR tyrosine kinase inhibitors…”
Get full text